Valuation: Stryker Corporation

Market Cap 129B 112B 105B 95.96B 180B 12,321B 183B 1,226B 481B 6,173B 486B 475B 20,417B P/E 2026 *
26.2x
P/E 2027 * 22.8x
Enterprise Value 139B 120B 112B 103B 193B 13,190B 196B 1,313B 515B 6,608B 520B 509B 21,856B EV / Sales 2026 *
5.08x
EV / Sales 2027 * 4.56x
Free-Float
94.9%
Yield 2026 *
1.07%
Yield 2027 * 1.14%
1 week-4.86%
Current month+3.79%
1 month+3.01%
1 week 13.3
Extreme 13.3
13.9
1 month 12.6
Extreme 12.6
14.4
Current year 12
Extreme 12
14.4
1 year 12
Extreme 12
14.4
3 years 12
Extreme 12
14.4
5 years 12
Extreme 12
14.4
10 years 12
Extreme 12
14.4
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
Director of Finance/CFO 50 01/04/2025
President 49 01/01/2026
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.86% - - 129B
+0.47%-2.59%-9.58%+19.50% 129B
+1.37%-6.31%-16.79%-1.20% 12.43B
+5.28%+6.82%+103.44%+141.90% 10.08B
+2.59%-2.36%-42.76%-68.89% 4.58B
+2.93%+0.77%-14.62%+40.45% 2.62B
+2.16%+20.27%-23.31%-78.30% 1.7B
+2.82%+1.41%-14.77%-17.47% 1.64B
+2.16%+0.31%-30.10%-31.98% 1.63B
Average +2.20%+1.24%-6.06%+0.50% 20.51B
Weighted average by Cap. +0.55%-2.68%-4.59%+21.42%

Financials

2026 *2027 *
Net sales 27.29B 23.62B 22.04B 20.23B 38.03B 2,598B 38.62B 259B 101B 1,302B 102B 100B 4,305B 29.68B 25.68B 23.97B 22.01B 41.36B 2,826B 42B 281B 110B 1,416B 111B 109B 4,682B
Net income 4.94B 4.28B 3.99B 3.66B 6.89B 470B 6.99B 46.83B 18.36B 236B 18.55B 18.15B 780B 5.75B 4.97B 4.64B 4.26B 8.01B 547B 8.13B 54.45B 21.34B 274B 21.57B 21.11B 906B
Net Debt 9.13B 7.9B 7.37B 6.77B 12.72B 869B 12.91B 86.47B 33.89B 435B 34.26B 33.52B 1,439B 5.89B 5.1B 4.76B 4.37B 8.21B 561B 8.33B 55.79B 21.87B 281B 22.11B 21.63B 929B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change
07/08/26 €13.70 0.00%
06/08/26 €13.70 0.00%
05/08/26 €13.70 -1.44%
04/08/26 €13.90 +4.51%
03/08/26 €13.30 +0.76%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
337.43USD
Average target price
382.04USD
Spread / Average Target
+13.22%

Quarterly revenue - Rate of surprise